Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 02/02/20161 min de leitura
Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; General Licensing Provisions; Section 351(k) Biosimilar Applications
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is announcing that a collection of information entitled "General Licensing Provisions; Section 351(k) Biosimilar Applications" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →